Cite
HARVARD Citation
Bang, Y. et al. (2020). Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ). European journal of cancer. pp. 272-284. [Online].